Evidence map›Paper›PMID 36509996›Full record

ArticleEye (London, England)2023

Phenotypic characterization of autosomal dominant progressive cone dystrophies associated with a heterozygous variant c.2512C>T of GUCY2D gene in a large kindred.

Yunxia Gao, Xiang Ren, Hong Lin, Kang Li, Lirong Xiao, Xiaoyue Wang, Zhibing Zeng, Ruijin Ran, Yunhan Tao, Yu Lin and 3 more

Open access · greenAbstract read
In one paragraph

Article in Eye (London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Identification of novel mutations in theInternational journal of ophthalmology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Yunxia Gao *Department of Ophthalmology, Ophthalmic Laboratory, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, PR China.ORCID 0000-0003-3707-812X
Xiang Ren *Department of Ophthalmology, Ophthalmic Laboratory, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, PR China.
Hong LinDepartment of Ophthalmology, Ophthalmic Laboratory, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, PR China.
Kang LiDepartment of Ophthalmology, Ophthalmic Laboratory, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, PR China.
Lirong XiaoResearch Laboratory of Ophthalmology and Vision Sciences, State Key Laboratory of Biotherapy; West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, PR China.
Xiaoyue WangDepartment of Ophthalmology, Ophthalmic Laboratory, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, PR China.
Zhibing ZengDepartment of Ophthalmology, Ophthalmic Laboratory, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, PR China.
Ruijin RanDepartment of Ophthalmology, Ophthalmic Laboratory, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, PR China.
Yunhan TaoDepartment of Ophthalmology, Ophthalmic Laboratory, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, PR China.
Yu LinDepartment of Ophthalmology, Ophthalmic Laboratory, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, PR China.
Xiangyu FuDepartment of Ophthalmology, Ophthalmic Laboratory, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, PR China.
Naihong YanResearch Laboratory of Ophthalmology and Vision Sciences, State Key Laboratory of Biotherapy; West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, PR China. yannaihong@126.com.
Ming ZhangDepartment of Ophthalmology, Ophthalmic Laboratory, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, PR China. zhangmingscu0905@163.com.
Sichuan University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIn this study, we described a large family presenting different manifestations of cone dystrophy at different ages associated with GUCY2D gene mutation.

methodSixty-three individuals of a single kindred, including 23 affected with cone dystrophies, were recruited and received ocular examinations, including best corrected visual acuity, intraocular pressure, slit-lamp biomicroscopy, color fundus photograph (CFP), fundus autofluorescence, optical coherence tomography, fluorescence fundus angiography, color vision testing, full-field electroretinography, and electro-oculogram. Whole exome sequencing (WES) and Sanger sequencing were performed for underlying mutations associated with cone dystrophy.

resultThere were 23 affected family members. Clinical analysis showed that the proband and other patients had impaired visual acuity ranging from 20/800 to 20/50 with impaired color vision. Fundus photograph showed retinal pigment epithelium (RPE) granular abnormalities with depressed macular reflex in young patients and macular or retinochoriodal atrophy in older patients. OCT examination confirmed the reduced outer retinal thickness or inner retinal thickness, absence of the ellipsoid zone (EZ) and retinal atrophy to varying degrees. Electroretinography revealed a reduced cone response combined with a relatively maintained rod response. WES and Sanger sequencing revealed a heterozygous variant c.2512C>T in the GUCY2D gene of the affected family members.

conclusionsWe reported cone dystrophy in 23 affected individuals in a five-generation family and demonstrated different macular abnormalities in OCT scans and CFP at different ages. The multimodal ocular records in our study provide physicians and ophthalmologists with a better understanding of cone dystrophy associated with GUCY2D mutation.

Indexed as

Cone DystrophyRetinal DegenerationAgedAtrophyElectroretinographyHumansMutationPedigreePhenotypeRetinal Cone Photoreceptor CellsTomography, Optical Coherence

Identifiers

PMID36509996
PMCPMC10397296
OpenAlexW4311822704

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.